Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2022 Sep 19;89(2):499–507. doi: 10.1002/mrm.29456

The future is 2D: spectral‐temporal fitting of dynamic MRS data provides exponential gains in precision over conventional approaches

Assaf Tal 1,
PMCID: PMC10087547  PMID: 36121336

Abstract

Purpose

Many MRS paradigms produce 2D spectral‐temporal datasets, including diffusion‐weighted, functional, and hyperpolarized and enriched (carbon‐13, deuterium) experiments. Conventionally, temporal parameters—such as T2, T1, or diffusion constants—are assessed by first fitting each spectrum independently and subsequently fitting a temporal model (1D fitting). We investigated whether simultaneously fitting the entire dataset using a single spectral‐temporal model (2D fitting) would improve the precision of the relevant temporal parameter.

Methods

We derived a Cramer Rao lower bound for the temporal parameters for both 1D and 2D approaches for 2 experiments: a multi‐echo experiment designed to estimate metabolite T2s, and a functional MRS experiment designed to estimate fractional change (δ) in metabolite concentrations. We investigated the dependence of the relative standard deviation (SD) of T2 in multi‐echo and δ in functional MRS.

Results

When peaks were spectrally distant, 2D fitting improved precision by approximately 20% relative to 1D fitting, regardless of the experiment and other parameter values. These gains increased exponentially as peaks drew closer. Dependence on temporal model parameters was weak to negligible.

Conclusion

Our results strongly support a 2D approach to MRS fitting where applicable, and particularly in nuclei such as hydrogen and deuterium, which exhibit substantial spectral overlap.

Keywords: dynamic fitting, dynamic MRS, magnetic resonance spectroscopy (MRS), quantification

Short abstract

Click here for author‐reader discussions

1. INTRODUCTION

Dynamic MRS refers to an experiment in which a series of 1D spectra are acquired sequentially, often while varying a sequence parameter or administering an external time‐dependent stimulus or manipulation. This encompasses a wide range of experimental designs, including observation of the dynamic incorporation of carbon‐13 and deuterium–labeled metabolites following the injection of a labeled compound 1 , 2 , 3 , 4 , 5 , 6 , 7 ; functional MRS designed to detect endogenous metabolic changes in glutamate, GABA, and lactate in response to an external visual, motor, or cognitive manipulation 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ; multiparametric MR spectroscopic experiments aimed at simultaneously and efficiently quantifying multiple spin parameters 21 , 22 , 23 , 24 , 25 , 26 ; diffusion MRS whereby the diffusion‐weighting gradients are varied to quantify the diffusion coefficient of different metabolites 27 , 28 , 29 , 30 , 31 , 32 ; and even simple relaxometry, where, for example, T2 might be measured by measuring spectral data at different TEs (MTE). 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41

The analysis of the 2D spectral‐temporal data sets produced by dynamic MRS experiments is conventionally done piecewise in two stages. First, each spectrum is fit using a linear combination of basis functions 42 , 43 , 44 , 45 , 46 , 47 , 48 to extract the temporal dependence of each metabolite's amplitudes. Then, the time‐series for each metabolite's amplitude is fit to the dynamic model, which describes the temporal behavior to extract the relevant temporal constants, such as T1 or T2, diffusion coefficients, or metabolite kinetics, depending on the experiment in question. We will refer to this approach as piecewise, or 1D. Recently, it has been suggested that multiple spectra comprising a dynamic data set should be analyzed and fitted in tandem rather than sequentially using a model that combines the spectral and temporal degrees of freedom. 42 , 49 , 50 , 51 Such an approach utilizes the temporal correlations inherent in the data to benefit the spectral estimations of metabolite amplitudes, and—in principle—should provide more precise and accurate estimates of the temporal constants. We will refer to such approaches as dynamic, or 2D. The two approaches are contrasted schematically in Figure 1.

FIGURE 1.

MRM-29456-FIG-0001-c

A schematic overview of 1D (piecewise) versus 2D (dynamic) fitting schemes for a fictitious multi‐echo MRS experiment designed to estimate the T2. (Top) In 1D fitting, data is initially fit to a spectral model to extract the relevant spectral parameters, θ(ν), such as the area (or amplitude) of each spectral peak or metabolite basis function. These are then fit to the relevant temporal model to extract the relevant temporal parameters, θ(t), which for a multi‐echo experiment include T2. (Bottom) In 2D fitting, the entire spectral‐temporal dataset is fit simultaneously to a spectral‐temporal model. Such fitting simultaneously furnishes all spectral and temporal parameters—for example, T2 for a multi‐echo experiment

In the current work, we set out to investigate the theoretical gains in precision offered by 2D fitting of dynamic MRS data relative to the more conventional 1D approach. Rather than quantifying the exact improvements, which would invariably depend on the specific details of the temporal and spectral models, we instead asked ourselves two questions: First, is 2D fitting indeed uniformly superior to 1D fitting? And, if so, which specific spectral or temporal features—or combination thereof—yielded the most substantial gains? To answer these, we assumed a simple spectral model consisting of two Gaussian peaks, and investigated two temporal models: an MTE relaxometry experiment designed to estimate T2 (which, formally, is equivalent to a diffusion‐weighted experiment designed to estimate the apparent diffusion coefficient), and a functional MRS (fMRS) experiment in which one of the peaks changes in response to an external stimulus, whereas the other remains unchanged. For each model (MTE, fMRS) and each approach (1D, 2D), we calculated the Cramer Rao lower bound (CRLB), 52 , 53 a theoretical estimate on the variance of the relevant dynamical parameter—T2 (MTE) and fractional metabolite change (fMRS)—and explored the relative gain in precision offered by 2D fitting.

2. METHODS

2.1. Models

Our spectral model ν|θ(ν) consisted of the sum of two Gaussian lineshapes, each with a respective amplitude (A), center (μ), and linewidth (Δ):

ν|θ(ν)=Gν|A1,μ1,Δ1+Gν|A2,μ2,Δ2, (1)

with θ(ν)=A1,μ1,Δ1,A2,μ2,Δ2, and

G(ν|A,μ,Δ)=A·exp(νμ)22Δ2. (2)

In this notation, ν is the independent frequency variable, whereas A, μ, and Δ are the model parameters (Figure 2A).

FIGURE 2.

MRM-29456-FIG-0002-c

An illustration of the spectral and temporal models under investigation, without any added noise. (A) The spectral model, which consists of two Gaussians, for several values of the distance parameter d (Equation (5)). Additional parameters: unit amplitudes, FWHM of 8 Hz, SW = 64 Hz, 64 sampled points. (B) MTE temporal‐spectral data with equal amplitudes, FWHM = 8 Hz, d = 1.5, T2,A=T2,B=200 ms, TE=0,0.05,0.35 s. (C) fMRS temporal‐spectral data with FWHM = 8 Hz, d = 1.5, equal amplitudes, δA=0, δB= 0.2, kA=kB=2 s, pulse TR = 2 s. The red‐shaded patch indicates the presence of the external stimulus between 30 and 90 s. The two purple solid curves trace the maxima of the 2 peaks as a function of time, showing their temporal dynamics: 1 peak remains unaffected by the stimulus δA=0, whereas the other increases and then returns to baseline δB=0.2 fMRS, functional MRS; MTE, multi‐echo.

We considered two temporal models. The first temporal model is that of a MTE experiment (Figure 2B) in which the signal decays exponentially with a time constant T 2 as a function of the TE:

TMTETE|θ(t)=TMTETE|s0,T2=s0·expTET2, (3)

with θ(t)=s0,T2 the vector of temporal constants. We note that an MTE experiment is formally equivalent to a simple diffusion‐weighted experiment in which peak amplitudes decay exponentially with a time constant given by the apparent diffusion coefficient D as a function of the b value, which is altered by changing the diffusion‐encoding gradient amplitudes (so θ(t)=s0,D). The full 2D dynamic model for each peak consisted of the outer product of the spectral and temporal models, with 1 minor modification. The amplitude parameter s0 in the temporal model was set to unity, given that the spectral amplitudes A1, A2 can be used to adjust the overall amplitude of each peak:

TMTE(2D)(ν,TE|θ)=TMTE(2D)ν,TE|A1,μ1,Δ1,T2,A,A2,μ2,Δ2,T2,B=Gν|A1,μ1,Δ1·TMTETE|1,T2,A+Gν|A2,μ2,Δ2·TMTETE|1,T2,B..

The second temporal model is that of an fMRS experiment using a single‐condition block design (Figure 2C). Such a design is described the convolution of a boxcar function H(t) of unit amplitude between some initial (ti) and final (tf) times—representing the external stimulus, such as a visual checkerboard pattern—and a point spread function (PSF), which we have taken to be Gaussian with a width σ: PSF(t|δ,k)=Gt|2πk2δ,3k,k. This ensures that the fractional change in the metabolite's amplitude will be given by δ. The shift 3k ensures causality, effectively zeroing out the temporal dynamics prior to the administration of the stimulus. Thus,

TfMRSt|θ(t)=TfMRSt|s0,δ,k=s0(1+(PSFH)(t))=s01+δ2erftft2k2erftit2k2,

whereas the full 2D spectral‐temporal model is:

TfMRS(2D)(ν,t|θ)=TfMRS(2D)ν,t|A1,μ1,Δ1,δA,kA,A2,μ2,Δ2,δB,kB=Gν|A1,μ1,Δ1·TfMRSt|1,δA,kA+Gν|A2,μ2,Δ2·TfMRSt|1,δB,kB.

This temporal model can also be used to describe the incorporation of a labeled nucleus—such as deuterium or carbon‐13—in the observable peaks as it undergoes different metabolic cycles within the tissue.

2.2. Cramer Rao lower bounds (CRLBs)

For all models, we assume the acquired data contains additive, normally distributed noise with zero mean. Under this simplification, the Fisher information matrix for a model with η=η1(θ),η2(θ),,ηN(θ) measurements, which depend on M parameters θ=θ1,θ2,,θM, has matrix elements given by:

Fmn=ηTθm1ηθn+12trace1θm1θn, (4)

where is the N×N covariance matrix of the N measurements.

For the full 2D models, the covariance matrix is diagonal and proportional to the identity, =σn2I, with the noise's variance being σn2. The means are all independent, drawn from the same distribution, and given by the relevant model expression; for example, for MTE MRS, ηjNTMTE(2D)(ν,t|θ),σ2. This implies the derivatives of the covariance matrix are all zero, and the second term in Equation (4) can be omitted. The M×M CRLB matrix is derived by inverting the M×M Fisher information matrix and equals to covariance matrix of the parameters in θ. The square root of its diagonal provides the lower bound on the standard deviation (SD) of each parameter in θ, including the relevant temporal constant (e.g., T 2,A and T 2,B for MTE MRS). Note that if N(ν) points are sampled along the spectral dimension and N(t) spectra are acquired along the temporal dimension, then the number of independent measurements is N=N(ν)N(t).

For piecewise 1D fitting approaches, the analysis is slightly more involved: First, the 1D spectral model (Equation (1)) is fitted, and then the amplitude of each peak is fit to the corresponding 1D temporal model to extract the relevant temporal constant. Consequently, Equation (4) is first computed and inverted to calculate the 6×6 covariance matrix of the 6 spectral parameters in θ(ν) (σn is assumed the same as for the full 2D model). The 2×2 covariance submatrix for the two amplitudes A1,A2 is then extracted for each 1D spectrum, and N(t) such covariance matrices are then chained together along the diagonal to produce a 2N(t)×2N(t) covariance matrix for the temporal model; the block diagonal form reflects the statistical dependence of the two spectral amplitudes, which becomes nonnegligible once the peaks overlap. The expression for the mean, ηkθ(t), is given by the corresponding expression for the 1D temporal model (e.g., Equation (3) for MTE MRS). Calculating and inverting Equation (4) produces the covariance matrix of the temporal parameters, and the square root of its diagonal yields the SDs of each of the temporal constants. The MATLAB code for carrying out the calculations of the CRLB is provided as Supporting Information.

2.3. Spectral parameters

Because spectral lines tend to have very similar linewidths, we set the widths of our Gaussian lines to be identical throughout: Δ1=Δ2Δ=2.355·FWHM. Typical spectral lineshapes are approximately 5–10 Hz, and we set FWHM = 8 Hz. For all simulations, we defined a distance parameter,

dμ2μ12·FWHM, (5)

which quantified the closeness of the two Gaussian peaks. d1 implies little to no overlap, whereas d1 and lower signifies significant overlap.

Because the CRLB matrices are always proportional to σn2, the variance of the noise in the spectra, and because we were only interested in relative SDs between the two approaches, the absolute value of σn was irrelevant and set to unity. The spectral range was set to [32,32] Hz and sampled at a spectral resolution of 1 Hz, equivalent to a typical FID acquisition time of 1 s, with N(ν)=64.

2.4. Temporal parameters: MTE

For MTE MRS, we investigated the relative SD of the two decay constants T2,A and T2,B between the two fitting approaches as a function of d. First, we considered 3 cases of equal T2s: T2,A=T2,B=50,100, and 200 ms. We also calculated the effect of unequal T2s by fixing T2,A=100ms and varying T2,B between 30 and 300 ms for two values of d: d = 0.7 and d = 1.4. For all cases, the following TEs were sampled: TE=0,50,100,,350 ms; This resulted in a 2D dataset with N(ν)×N(t)=64×8=512 data points.

2.5. Temporal parameters: fMRS

For fMRS, we investigated the relative SD of the fractional change during activation, δ, between the two fitting approaches. We assumed a 2 min experiment with TR = 2 s and a 60 s boxcar stimulus administered between 30 and 90 s. Only 1 of the peaks was assumed to change, whereas the other remained static (δB0,δA=0). We plotted the SD of the fractional change δ for each of the two peaks as a function of d for both the fast (k = 2 s) and slow (k = 15 s) metabolite dynamics, for δB=0.05,0.1, and 0.2. We then explored the effect of the activation timescale, k, for two spectral peak distances, d=0.8,1.5, assuming δB=0.1. For each case, the resulting 2D dataset consisted of N(ν)×N(t)=64×60=3840 data points.

3. RESULTS

3.1. Multi‐echo (MTE) MRS

The relative gains in precision of T2 offered by 2D fitting are summarized in Figure 3. Figure 3A shows that the relative SD is independent of T2 as long as T2,B=T2,A. When the peaks have little to no spectral overlap (d1 and above), this relative gain is 20%. This increases exponentially as the peaks begin to overlap (d0), indicating that 2D fitting could be a powerful tool in resolving the overlap of metabolites in crowded spectra. Figure 3B shows that some variation (±20%) in the gain is to be expected when T2,BT2,A and the peaks overlap spectrally (d = 0.7), with the optimal performance being observed for T2,B=T2,A. No variation is observed when the peaks do not overlap (d = 1.5). Finally, Figure 3C —plotted for quality assurance—confirms that the spectral peak amplitudes have no effect on the relative performance because the CRLB matrix is proportional to the SNR for both 1D and 2D fittings, and this dependence cancels out once the 1D/2D ratio is formed.

FIGURE 3.

MRM-29456-FIG-0003-c

Results: Relative (1D/2D) SD of T2 in an MTE experiment. Solid lines are for peak A, whereas dashed lines are for peak B. Unless otherwise stated, TE=0,0.05,,0.35 s, Spectral Width = 64 Hz, N(ν)=64 spectral points, FWHM = 8 Hz, and amplitudes are kept equal. (A) Relative SD as a function of the distance d between the spectral peaks for several values of T 2, which were kept equal between the two peaks. All curves match almost perfectly, indicating that the relative performance is independent of the absolute value of T 2 so long as T2,A=T2,B. This also indicates performance of 2D fitting becomes exponentially better as the peaks begin to spectrally overlap. (B) Relative SD for two distances (d = 0.7, 1.4) while varying the ratio T2,B/T2,A (fixing T2,A=0.1 s). When the peaks are far apart, the relative performance is independent of the absolute value of T 2 (in accordance with (A)). When overlap occurs, 2D fitting provides the best relative performance when the relaxation times are equal. (C) The relative SD is a function of the ratio of amplitudes of the two peaks (fixing A 1 = 1) for two different spectral distances (d = 0.7, 1.4), keeping the amplitude of the first peak fixed at unity. This “sanity check” confirms that, as expected, the performance is independent of the SNR because the SD of the noise cancels out once the ratio of the CRLBs (1D/2D) is taken. For all plots, as d1, the relative performance of 2D fitting remains fixed at approximately 1.2 (see Discussion section for an explanation of this)CRLBs, Cramer Rao lower bounds.

3.2. Functional MRS (fMRS)

The relative gains in precision of δ, the fractional change in metabolite concentration, offered by 2D fitting are summarized in Figure 4. The overall behavior of the relative SD is highly similar between fMRS and MTE MRS: when the peaks do not overlap, the relative gain in precision for 2D fitting is approximately 20%, regardless of all other model parameters; this gain grows exponentially as d0. This is confirmed for both fast (Figure 4A) and slow (Figure 4B) temporal dynamics. Figure 4C shows the ratio of dynamical time constants kB/kA has a negligible (<5%) effect on the relative SD whether or not the peaks overlap spectrally.

FIGURE 4.

MRM-29456-FIG-0004-c

Results: Relative (1D/2D) SD of the fractional change in metabolite concentrations δ in an fMRS experiment. Solid lines are for peak A, whereas dashed lines are for peak B. Unless otherwise stated, TR = 2 s, TA = 2 min, and stimulus was administered between 30 and 90 s. Spectral parameters were Spectral Width = 64 Hz, N(ν)=64 spectral points, FWHM = 8 Hz, and equal amplitudes. (A) Relative SD as a function of the spectral distance d between the peaks for several values of δB (keeping δA=0) and fast temporal dynamics (kA=kB=2 s). All curves match almost perfectly, indicating that the relative performance is independent of the fractional change. As with the MTE model, this indicates performance of 2D fitting becomes exponentially better as the peaks begin to overlap spectrally. (B) The same as (a) but for slow temporal dynamics (kA=kB=15 s). This indicates the temporal dynamics has virtually no effect on the ability to quantify metabolite changes when kA=kB. (C) Relative SD as a function of the ratio kB/kA, keeping kA fixed at 5 s and varying kB, for two values of the spectral distance (d = 0.8, 1.5). This indicates that the ratio of temporal constants has non‐zero but negligible (<5%) effect on quantification precision, even when the peaks overlap. Much like for the MTE plots (Figure 3), the relative gain in precision for 2D fitting remains fixed at approximately 1.2 as d increases

4. DISCUSSION

In the Introduction, we have laid out two questions that we are now poised to answer: Is 2D fitting always superior to 1D fitting? And when does it achieve its biggest gains? First, our results confirm that 2D fitting is indeed uniformly superior to 1D fitting. For all parameter combinations considered and for all models, the ratio of SDs between 2D and 1D approaches exceed 1.2. The lower bound was attained for both models once the peaks did not overlap spectrally (d1), regardless of the value of all other parameters. This can be explained by noting that all 2D models fit 1 parameter fewer than their 1D counterparts: namely, the amplitude of the temporal model. 1D approaches initially fit the spectral peak amplitudes and then reintroduce an amplitude parameter in the temporal model (e.g., s 0 in Equation (3)). It is this redundancy that is avoided by 2D approaches, in which all scaling is done only once in the combined 2D model.

The precision offered by 2D fitting improved exponentially when the spectral overlap between the peaks increased (d0). This behavior was observed for both MTE and fMRS models, regardless of other parameter values. This strongly supports the notion that 2D fitting is a powerful tool for handling spectra with significant overlap—as is the case for proton and deuterium MRS, but less so for enriched carbon‐13 and phosphorus‐31 MRS. The effect of all other parameters was much less significant: The absolute value of the fractional change (δ) in an fMRS experiment, or the T2 relaxation time in an MTE experiment, has little effect on the relative quantification precision. In particular, as long as T2,A=T2,B in an MTE experiment, its absolute value had virtually no effect on precision, and different T2,B/T2,A ratios (from 0.3 to 3.0) led to only a ±20% deviation in relative precision.

Where do the substantial gains in precision come from as d0? When the spectral peaks are far apart (d1), the 6 × 6 CRLB matrix for the spectral components is block diagonal because the parameters of the first peak (amplitude, center, and width) are uncorrelated with those of the second peak. As the spectral peaks overlap, the CRLB deviates from this block diagonal form, and substantial spectral correlations form. 1D fitting records the individual values of the fitted spectral parameters, effectively tracing out these off‐diagonal matrix elements and discarding crucial information about their correlations. No such tracing occurs during 2D fitting.

To put the relative gains of 2D fitting in perspective, we note that an N‐fold increase in precision is equivalent to an N‐fold increase in SNR. Such gains can reduce the sample size N s required to observe an effect with a given statistical significance α and power (1β) 54 :

Ns=z1ασBzβσA2μBμA2.

Here, σB,μB are the SD and mean of the distribution of a quantity (e.g., percent change, or T2) in population B (e.g., patients), whereas σA,μA are the SD and mean in population A (e.g., controls). z x is the inverse of the normal cumulative distribution function. For typical values of α=0.05, β=0.2, one has z1α=1.645 and zβ=0.842. Reducing the SD of both populations by a factor of two reduces the required sample size by a factor of 4—a substantial gain in experimental time, cost, and complexity (however, it should be noted that in a real experiment, σA,σB will be determined by both the intrasubject precision—which 2D fitting improves—and intersubject variability, on which 2D fitting has no effect). Even for the case of no spectral overlap, where gains of about 20% in precision are to be expected, a commensurate reduction of 1.221.44 in the required sample size can be had. Similar substantive gains can be had in sensitivity and specificity, indicating 2D fitting can have a major impact on MRS in both the clinic and biomedical research.

4.1. Improvements to accuracy

The current work has examined gains to precision by calculating the CRLB for both 1D and 2D approaches to fitting spectral‐temporal data. The CRLB provides a lower bound for unbiased estimators; that is, this work has implicitly assumed that the fitting algorithms used are unbiased and therefore perfectly accurate. This is not uncommon: the Gauss–Markov theorem states that minimizing the least squares (i.e., L2‐norm) between the data and model function—an approach often taken during fitting spectral data—produces unbiased parameter estimations witha precision that matches the CRLB (regardless of the SNR, and assuming noise is uncorrelated and has equal variances, which is the case for MRS data). However, our conclusions should be treated with some caution if the fitting is expected or known to produce biased parameter estimations, for example, if one chooses to minimize some other norm, such as L 1.

Another source of bias occurs when either the spectral or temporal models do not describe the behavior of the data. Incorrect models will invariably bias the fitting results for both the 1D and 2D approaches, although it is unclear whether it should affect one or the other more severely. Assessing the effects of incorrect modeling is outside the scope of this work, which has carried out comparisons under the assumption that the temporal model is known and almost identical between the 1D and 2D approaches.

5. CONCLUSION

By calculating the theoretical CRLB for both 1D and 2D approaches, we have shown that 2D fitting uniformly outperforms 1D fitting, with exponential gains when peaks overlap spectrally. Our work strongly motivates the transition to spectral‐temporal fitting packages for all dynamic MRS datasets.

Supporting information

Appendix S1 Matlab computer co

ACKNOWLEDGMENT

This work was supported by the Israeli Science Foundation (ISF) personal grant 416/20. a.t. acknowledges the support of the Monroy‐Marks Career Development Fund and the historic generosity of the Harold Pearlman Family.

Tal A. The future is 2D: spectral‐temporal fitting of dynamic MRS data provides exponential gains in precision over conventional approaches. Magn Reson Med. 2023;89:499‐507. doi: 10.1002/mrm.29456

funding information

This work was supported by the Israeli Science Foundation (ISF) personal grant 416/20. a.t. acknowledges the support of the Monroy‐Marks Career Development Fund and the historic generosity of the Harold Pearlman Family.

Funding information Israel Science Foundation, Grant/Award Number: 416/20

Click here for author‐reader discussions

DATA AVAILABILITY STATEMENT

The documented MATLAB code used to calculate the CRLB bounds for the 1D and 2D approaches described in this work is provided as‐is in the Supporting Information.

REFERENCES

  • 1. de Feyter HM, Behar KL, Corbin ZA, et al. Deuterium metabolic imaging (DMI) for MRI‐based 3D mapping of metabolism in vivo. Sci Adv. 2018;4:eaat7314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Lu M, Zhu X‐H, Zhang Y, Mateescu G, Chen W. Quantitative assessment of brain glucose metabolic rates using in vivo deuterium magnetic resonance spectroscopy. J Cereb Blood Flow Metab. 2017;37:3518‐3530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Kreis F, Wright AJ, Hesse F, Fala M, Hu D, Brindle KM. Measuring tumor glycolytic flux in vivo by using fast deuterium MRI. Radiology. 2020;294:289‐296. [DOI] [PubMed] [Google Scholar]
  • 4. Lizarbe B, Lei H, Duarte JMN, Lanz B, Cherix A, Gruetter R. Feasibility of in vivo measurement of glucose metabolism in the mouse hypothalamus by 1H‐[13C] MRS at 14.1T. Magn Reson Med. 2018;80:874‐884. [DOI] [PubMed] [Google Scholar]
  • 5. de Graaf RA, Rothman DL, Behar KL. State of the art direct 13C and indirect 1H‐[13C] NMR spectroscopy in vivo. A practical guide. NMR Biomed. 2011;24:958‐972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Rothman DL, de Graaf RA, Hyder F, Mason GF, Behar KL, De Feyter HM. In vivo 13C and 1H‐13C MRS studies of neuroenergetics and neurotransmitter cycling, applications to neurological and psychiatric disease and brain cancer. NMR Biomed. 2019;32:e4172. [DOI] [PubMed] [Google Scholar]
  • 7. Rothman DL, de Feyter HM, de Graaf RA, Mason GF, Behar KL. 13C MRS studies of neuroenergetics and neurotransmitter cycling in humans. NMR Biomed. 2011;24:943‐957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Mangia S, Simpson IA, Vannucci SJ, Carruthers A. The in vivo neuron‐to‐astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation. J Neurochem. 2009;109:55‐62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Stanley JA, Burgess A, Khatib D, et al. Functional dynamics of hippocampal glutamate during associative learning assessed with in vivo 1H functional magnetic resonance spectroscopy. Neuroimage. 2017;153:189‐197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Kolasinski J, Hinson EL, Divanbeighi Zand AP, Rizov A, Emir UE, Stagg CJ. The dynamics of cortical GABA in human motor learning. J Physiol. 2019;597:271‐282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Woodcock EA, Anand C, Khatib D, Diwadkar VA, Stanley JA. Working memory modulates glutamate levels in the dorsolateral prefrontal cortex during 1H fMRS. Front Psychiatry. 2018;9:66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Ligneul C, Fernandes FF, Shemesh N. High temporal resolution functional magnetic resonance spectroscopy in the mouse upon visual stimulation. Neuroimage. 2021;234:117973. [DOI] [PubMed] [Google Scholar]
  • 13. Jelen LA, King S, Mullins PG, Stone JM. Beyond static measures: a review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia. J Psychopharmacol. 2018;32:497‐508. [DOI] [PubMed] [Google Scholar]
  • 14. Mullins PG. Towards a theory of functional magnetic resonance spectroscopy (fMRS): a meta‐analysis and discussion of using MRS to measure changes in neurotransmitters in real time. Scand J Psychol. 2018;59:91‐103. [DOI] [PubMed] [Google Scholar]
  • 15. Koush Y, de Graaf RA, Jiang L, Rothman DL, Hyder F. Functional MRS with J‐edited lactate in human motor cortex at 4T. Neuroimage. 2019;184:101‐108. [DOI] [PubMed] [Google Scholar]
  • 16. Schaller B, Xin L, O'Brien K, Magill AW, Gruetter R. Are glutamate and lactate increases ubiquitous to physiological activation? A 1H functional MR spectroscopy study during motor activation in human brain at 7 Tesla. Neuroimage. 2014;93:138‐145. [DOI] [PubMed] [Google Scholar]
  • 17. Schaller B, Mekle R, Xin L, Kunz N, Gruetter R. Net increase of lactate and glutamate concentration in activated human visual cortex detected with magnetic resonance spectroscopy at 7 Tesla. J Neurosci Res. 2013;91:1076‐1083. [DOI] [PubMed] [Google Scholar]
  • 18. Volovyk O, Tal A. Increased glutamate concentrations during prolonged motor activation as measured using functional magnetic resonance spectroscopy at 3T. Neuroimage. 2020;223:117338. [DOI] [PubMed] [Google Scholar]
  • 19. Taylor R, Neufeld RW, Schaefer B, et al. Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color‐word Stroop task. NPJ Schizophr. 2015;1:15028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Bezalel V, Paz R, Tal A. Inhibitory and excitatory mechanisms in the human cingulate‐cortex support reinforcement learning: a functional proton magnetic resonance spectroscopy study. Neuroimage. 2019;184:25‐35. [DOI] [PubMed] [Google Scholar]
  • 21. Wang CY, Liu Y, Huang S, Griswold MA, Seiberlich N, Yu X. 31P magnetic resonance fingerprinting for rapid quantification of creatine kinase reaction rate in vivo. NMR Biomed. 2017;30:e3786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Lim S‐I, Widmaier MS, Wenz D, Yun J, Xin L. Time‐efficient relaxation measurements by 31P MR fingerprinting in human brain at 7T. bioRxiv 2022.05.23.493067. 2022. [Google Scholar]
  • 23. Kirov II, Tal A. Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: a review and analysis. Magn Reson Med. 2020;83:22‐44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. An L, Li S, Shen J. Simultaneous determination of metabolite concentrations, T1 and T2 relaxation times. Magn Reson Med. 2017;78:2072‐2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Kulpanovich A, Tal A. What is the optimal schedule for multiparametric MRS? A magnetic resonance fingerprinting perspective. NMR Biomed. 2021;34:e4196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kulpanovich A, Tal A. The application of magnetic resonance fingerprinting to single voxel proton spectroscopy. NMR Biomed. 2018;31:e4001. [DOI] [PubMed] [Google Scholar]
  • 27. Palombo M, Ligneul C, Najac C, et al. New paradigm to assess brain cell morphology by diffusion‐weighted MR spectroscopy in vivo. Proc Natl Acad Sci U S A. 2016;113:6671‐6676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Palombo M, Shemesh N, Ronen I, Valette J. Insights into brain microstructure from in vivo DW‐MRS. Neuroimage. 2018;182:97‐116. [DOI] [PubMed] [Google Scholar]
  • 29. Branzoli F, Ercan E, Valabrègue R, et al. Differentiating between axonal damage and demyelination in healthy aging by combining diffusion‐tensor imaging and diffusion‐weighted spectroscopy in the human corpus callosum at 7 T. Neurobiol. Aging. 2016;47:210‐217. [DOI] [PubMed] [Google Scholar]
  • 30. Shemesh N, Rosenberg JT, Dumez J‐N, Grant SC, Frydman L. Distinguishing neuronal from astrocytic subcellular microstructures using in vivo double diffusion encoded 1H MRS at 21.1 T. PloS One. 2017;12:e0185232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Wood ET, Ercan AE, Branzoli F, et al. Reproducibility and optimization of in vivo human diffusion‐weighted MRS of the corpus callosum at 3T and 7T. NMR Biomed. 2015;28:976‐987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Genovese G, Marjańska M, Auerbach EJ, et al. In vivo diffusion‐weighted MRS using semi‐LASER in the human brain at 3 T: methodological aspects and clinical feasibility. NMR Biomed. 2021;34:e4206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Lopez‐Kolkovsky AL, Mériaux S, Boumezbeur F. Metabolite and macromolecule T1 and T2 relaxation times in the rat brain in vivo at 17.2T. Magn Reson Med. 2016;75:503‐514. [DOI] [PubMed] [Google Scholar]
  • 34. Murali‐Manohar S, Borbath T, Wright AM, Soher B, Mekle R, Henning A. T2 relaxation times of macromolecules and metabolites in the human brain at 9.4 T. Magn Reson Med. 2020;84:542‐558. [DOI] [PubMed] [Google Scholar]
  • 35. Kirov II, Liu S, Fleysher R, et al. Brain metabolite proton T2 mapping at 3.0 T in relapsing‐remitting multiple sclerosis. Radiology. 2010;254:858‐866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. An L, Araneta MF, Victorino M, Shen J. Determination of brain metabolite T1 without interference from macromolecule relaxation. J Magn Reson Imaging. 2020;52:1352‐1359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Cudalbu C, Mlynárik V, Xin L, Gruetter R. Comparison of T1 relaxation times of the neurochemical profile in rat brain at 9.4 tesla and 14.1 Tesla. Magn Reson Med. 2009;62:862‐867. [DOI] [PubMed] [Google Scholar]
  • 38. Xin L, Schaller B, Mlynarik V, Lu H, Gruetter R. Proton T1 relaxation times of metabolites in human occipital white and gray matter at 7 T. Magn Reson Med. 2013;69:931‐936. [DOI] [PubMed] [Google Scholar]
  • 39. Xin L, Gambarota G, Mlynárik V, Gruetter R. Proton T2 relaxation time of J‐coupled cerebral metabolites in rat brain at 9.4T. NMR Biomed. 2008;21:396‐401. [DOI] [PubMed] [Google Scholar]
  • 40. Wright AM, Murali‐Manohar S, Borbath T, Avdievich NI, Henning A. Relaxation‐corrected macromolecular model enables determination of 1H longitudinal T1‐relaxation times and concentrations of human brain metabolites at 9.4T. Magn Reson Med. 2022;87:33‐49. [DOI] [PubMed] [Google Scholar]
  • 41. Kirov II, Fleysher L, Fleysher R, Patil V, Liu S, Gonen O. Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T. Magn Reson Med. 2008;60:790‐795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Clarke WT, Stagg CJ, Jbabdi S. FSL‐MRS: An end‐to‐end spectroscopy analysis package. Magn Reson Med. 2021;85:2950‐2964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14:260‐264. [DOI] [PubMed] [Google Scholar]
  • 44. Oeltzschner G, Zöllner HJ, Hui SCN, et al. Osprey: open‐source processing, reconstruction & estimation of magnetic resonance spectroscopy data. J Neurosci Methods. 2020;343:108827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Wilson M, Reynolds G, Kauppinen RA, Arvanitis TN, Peet AC. A constrained least‐squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data. Magn Reson Med. 2011;65:1‐12. [DOI] [PubMed] [Google Scholar]
  • 46. Young K, Soher BJ, Maudsley AA. Automated spectral analysis II: application of wavelet shrinkage for characterization of non‐parameterized signals. Magn Reson Med. 1998;40:816‐821. [DOI] [PubMed] [Google Scholar]
  • 47. Gajdošík M, Landheer K, Swanberg KM, Juchem C. INSPECTOR: free software for magnetic resonance spectroscopy data inspection, processing, simulation and analysis. Sci Rep. 2021;11:2094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Edden RAE, Puts NAJ, Harris AD, Barker PB, Evans CJ. Gannet: a batch‐processing tool for the quantitative analysis of gamma‐aminobutyric acid–edited MR spectroscopy spectra. J Magn Reson Imaging. 2014;40:1445‐1452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Chong DGQ, Kreis R, Bolliger CS, Boesch C, Slotboom J. Two‐dimensional linear‐combination model fitting of magnetic resonance spectra to define the macromolecule baseline using FiTAID, a fitting tool for arrays of interrelated datasets. MAGMA. 2011;24:147‐164. [DOI] [PubMed] [Google Scholar]
  • 50. Adalid V, Döring A, Kyathanahally SP, Bolliger CS, Boesch C, Kreis R. Fitting interrelated datasets: metabolite diffusion and general lineshapes. MAGMA. 2017;30:429‐448. [DOI] [PubMed] [Google Scholar]
  • 51. Clarke W, Ligneul C, Cottaar M, Jbabdi S. Dynamic fitting of functional MRS, diffusion weighted MRS, and edited MRS using a single interface. In Proceedings of the Joint Annual Meeting ISMRM‐ESMRMB & ISMRT 31st Annual Meeting, London, UK, 2022. p. 309.
  • 52. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron‐Demilly D. Cramér–Rao bounds: an evaluation tool for quantitation. NMR Biomed. 2001;14:278‐283. [DOI] [PubMed] [Google Scholar]
  • 53. Zhao B, Haldar JP, Liao C, et al. Optimal experiment design for magnetic resonance fingerprinting: Cramér‐rao bound meets spin dynamics. IEEE Trans Med Imaging. 2019;38:844‐861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Hoch SE, Kirov II, Tal A. When are metabolic ratios superior to absolute quantification? A statistical analysis. NMR Biomed. 2017;30:e3710. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Appendix S1 Matlab computer co

Data Availability Statement

The documented MATLAB code used to calculate the CRLB bounds for the 1D and 2D approaches described in this work is provided as‐is in the Supporting Information.


Articles from Magnetic Resonance in Medicine are provided here courtesy of Wiley

RESOURCES